These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3436681)

  • 21. [Prospects of clinical uses of quinolones in burn wound infections].
    Wang DW
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1990 Sep; 6(3):223-5. PubMed ID: 2276070
    [No Abstract]   [Full Text] [Related]  

  • 22. Wound infection due to Aeromonas sobria.
    Newton JA; Kennedy CA
    Clin Infect Dis; 1993 Dec; 17(6):1082-3. PubMed ID: 8110950
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of bacterial infections using ciprofloxacin in granulocytopenic patients with cancer].
    Snoeck R; Gerain J; Leleux A; Libert J; Meunier F
    Rev Med Brux; 1989 Dec; 10(10):408-13. PubMed ID: 2602729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?
    Murphy M; Brown AE; Sepkowitz KA; Bernard EM; Kiehn TE; Armstrong D
    Clin Infect Dis; 1997 Aug; 25(2):346-8. PubMed ID: 9332551
    [No Abstract]   [Full Text] [Related]  

  • 25. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1980 Dec; 2(8207):1263-5. PubMed ID: 6108445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
    Copeland V; McLaughlin M; Trifilio S
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29080369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Condie RM; Cerra FB
    Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy of gemifloxacin in experimental models of pyelonephritis and wound infection.
    Berry V; Page R; Satterfield J; Singley C; Straub R; Woodnutt G
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():87-93. PubMed ID: 10824038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vibrio vulnificus wound infection treated successfully with oral ciprofloxacin.
    Meadors MC; Pankey GA
    J Infect; 1990 Jan; 20(1):88-9. PubMed ID: 2299188
    [No Abstract]   [Full Text] [Related]  

  • 30. Improvement in survival with peptidyl membrane interactive molecule D4B treatment after burn wound infection.
    Gamelli RL; He LK; Liu H; Ricken JD
    Arch Surg; 1998 Jul; 133(7):715-20. PubMed ID: 9687998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.
    De Pauw BE; Donnelly JP; De Witte T; Nováková IR; Schattenberg A
    Bone Marrow Transplant; 1990 Mar; 5(3):179-82. PubMed ID: 2184908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.
    Arning M; Wolf HH; Aul C; Heyll A; Scharf RE; Scheider W
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():137-42. PubMed ID: 2286588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured mice.
    Elliott TB; Bolduc DL; Ledney GD; Kiang JG; Fatanmi OO; Wise SY; Romaine PL; Newman VL; Singh VK
    Int J Radiat Biol; 2015; 91(9):690-702. PubMed ID: 25994812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
    Louie TJ
    CMAJ; 1994 Mar; 150(5):669-76. PubMed ID: 8313286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and antibacterial efficacy of ciprofloxacin after single-shot prophylaxis during cholecystectomy.
    Kögler J; Hancke E; Marklein G; Stark GB; Schmitz A
    J Chemother; 1989 Jul; 1(4 Suppl):993-4. PubMed ID: 16312739
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of ciprofloxacin in animal models of infection.
    Andriole VT
    Am J Med; 1987 Apr; 82(4A):67-70. PubMed ID: 3555064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
    Lee DG; Choi SM; Choi JH; Yoo JH; Park YH; Kim YJ; Lee S; Min CK; Kim HJ; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Korean J Intern Med; 2002 Mar; 17(1):38-44. PubMed ID: 12014211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice.
    Hodgin LA; Drews J
    Infection; 1976; 4(2):5-10. PubMed ID: 789248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous ciprofloxacin for infections in cancer patients.
    Rolston KV; Haron E; Cunningham C; Bodey GP
    Am J Med; 1989 Nov; 87(5A):261S-265S. PubMed ID: 2589375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic prophylaxis after swan bite.
    Ebrey RJ; Hayek LJ
    Lancet; 1997 Aug; 350(9074):340. PubMed ID: 9251647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.